AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00- £14.35m
- £11.32m
- £5.05m
REG - Arecor Therapeutics - Year End Trading Update
AnnouncementREG - Arecor Therapeutics - Arecor announces update on INBRX-101
AnnouncementREG - Arecor Therapeutics - Arecor granted key European patent
AnnouncementREG - Arecor Therapeutics - Expansion of specialty hospital collaboration
AnnouncementREG - Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd
AnnouncementREG - Arecor Therapeutics - Agreement with global medical products company
AnnouncementREG - Arecor Therapeutics - Arecor Continues Collaboration with Lilly
AnnouncementREG - Arecor Therapeutics - Product with Arestat technology launched in Europe
AnnouncementREG - AIM - AIM Notice - 07/11/2023
AnnouncementREG - Arecor Therapeutics - Inhibrx milestone triggers payment to Arecor
AnnouncementREG - Arecor Therapeutics - Exercise of rollover options & Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Progress of Phase I clinical study of AT278
AnnouncementRCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2023
AnnouncementREG - Arecor Therapeutics - Arecor: positive Hikma FDA pre-IND meeting
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
AnnouncementREG - Arecor Therapeutics - Collaboration With Top 10 Global Pharma
AnnouncementREG - Arecor Therapeutics - Notice of Interim Results
AnnouncementREG - Arecor Therapeutics - Arecor Business Update
Announcement